Tomas DEIERBORG,Antonio SERRANO,Hakon LEFFLER,Ulf NILSSON
申请号：
US15300769
公开号：
US20170095496A1
申请日:
2015.04.08
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided is a method for treatment or prevention of α-synucleinopathies in a mammalian subject, the method comprising administering a therapeutically effective amount of at least one composition to the subject, wherein the composition comprises a molecule for pharmacological modulation of galectin activity in a mammalian brain.
